NCT00147615 - The Long-term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years | Biotech Hunter

Enrollment

140

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

June 30, 2006

Conditions

Hypertension

Interventions

DRUG

Eplerenone

Trial Locations (21)

27710

Pfizer Investigational Site, Durham

43205

Pfizer Investigational Site, Columbus

60068

Pfizer Investigational Site, Park Ridge

77030

Pfizer Investigational Site, Houston

77094

Pfizer Investigational Site, Katy

90048

Pfizer Investigational Site, Los Angeles

110029

Pfizer Investigational Site, New Delhi

117869

Pfizer Investigational Site, Moscow

119991

Pfizer Investigational Site, Moscow

127412

Pfizer Investigational Site, Moscow

194100

Pfizer Investigational Site, Saint Petersburg

194291

Pfizer Investigational Site, Saint Petersburg

196191

Pfizer Investigational Site, Saint Petersburg

214019

Pfizer Investigational Site, Smolensk

560034

Pfizer Investigational Site, Bangalore

43205-2696

Pfizer Investigational Site, Columbus

500 033

Pfizer Investigational Site, Hyderabad

600 008

Pfizer Investigational Site, Chennai

600 031

Pfizer Investigational Site, Chennai

400 012

Pfizer Investigational Site, Mumbai

Unknown

Pfizer Investigational Site, Saint Petersburg

All Listed Sponsors

lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY